Laddar...
Fine tuning chemotherapy to match BRCA1 status
Targeted cancer therapies have been primarily directed at inhibiting oncogenes that are overexpressed or constitutively active in tumors. It is thought that as the cell’s circuitry gets rewired by the constitutive activation of some pathways it becomes exquisitely dependent on this activity. Tumor c...
Sparad:
| Huvudupphovsmän: | , |
|---|---|
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
2010
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2925507/ https://ncbi.nlm.nih.gov/pubmed/20510205 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bcp.2010.05.015 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|